| Elanco’s IPO Would Free Eli Lilly to Focus on Pharmaceuticals | Frank Vinluan | 08/03/18 | Indiana |
| With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines | Ben Fidler | 06/11/18 | Boston |
| Moderna’s Billions: Will Building Big Before an IPO Pay Off? | Ben Fidler | 05/09/18 | Boston |
| Moderna, Still Private, Scoops Up Yet Another $500M | Ben Fidler | 02/01/18 | Boston |
| Dynavax Co-founder Takes Long View on Vaccine Development | Bruce V. Bigelow | 12/05/17 | San Diego |
| Amid Cash Crunch, Genocea to Dump Herpes Vaccine, Focus on Cancer Work | Ben Fidler | 09/25/17 | Boston |
| Sanofi Shores Up Flu Vaccine Business With Protein Sciences Deal | Frank Vinluan | 07/11/17 | New York |
| Dragonfly, Tyler Jacks’s Disney-Backed Startup, Gets $33M in Celgene Deal | Ben Fidler | 06/12/17 | Boston |
| SRI’s Michigan Office Will Help Develop New VEE Vaccine | Sarah Schmid Stevenson | 05/15/17 | Detroit Ann Arbor |
| FDA Nominee Scott Gottlieb To Anti-Vaccine Crowd: Get Over It | Alex Lash | 04/05/17 | National |
| How Battling New Epidemics Helps Fight Age-Old Killers | Mark Orr | 04/03/17 | Seattle |
| Sanofi’s Experience With Dengvaxia May Speed Development of Zika Vaccine | Alex Harding | 11/04/16 | Boston |
| Bio Roundup: Theranos Cuts, Alnylam Stops, Nobel Eats Its Own & More | Alex Lash | 10/07/16 | National |
| Elanco Reaches $885M Deal for Boehringer’s Pet Vaccines Portfolio | Frank Vinluan | 10/05/16 | Indiana |
| Genocea Touts Early Look at Placebo-Controlled Herpes Vaccine Study | Ben Fidler | 09/29/16 | Boston |
| Roundup: S3 Ventures, TMCx, George Peoples, Disruptors in Houston | Angela Shah | 08/25/16 | Texas |
| FluGen Starts Clinical Trial for Universal Flu Vaccine | Jeff Buchanan | 07/27/16 | Wisconsin |
| The Outbreaks Are Here, Where’s Our Response Plan? | Steve Reed | 07/25/16 | Seattle |
| The Xconversation: Vaccine Developer Meets Energy Innovator, Part II | Benjamin Romano | 03/30/16 | Seattle |
| The Xconversation: Vaccine Developer Meets Energy Innovator, Part I | Benjamin Romano | 03/29/16 | Seattle |
| Former Gates Foundation Lawyer Tapped As WARF’s New Managing Director | Jeff Buchanan | 03/24/16 | Wisconsin |
| Celldex’s Brain Cancer Vaccine Fails Key Phase 3 Test, Shares Fall | Ben Fidler | 03/07/16 | Boston |
| With New Startup, Caperna, Moderna Gets in on Cancer Vaccine Buzz | Ben Fidler | 10/22/15 | Boston |
| Cancer Vaccines Back in Vogue as VCs Put $102M Into Gritstone Oncology | Ben Fidler | 10/20/15 | San Francisco |
| Genocea Ditches Pneumococcus Vaccine After Phase 2 Flop, Shares Fall | Ben Fidler | 10/19/15 | Boston |
| Genocea Climbs on Follow-Up Data for Herpes Vaccine | Ben Fidler | 10/07/15 | Boston |
| CureVac Opens up an mRNA Hub in Moderna’s Cambridge Backyard | Ben Fidler | 09/10/15 | Boston |
| Selecta, Eyeing IPO, Brings Sanofi, Crossovers Aboard For $38M Round | Ben Fidler | 09/08/15 | Boston |
| With $22M Shot of Venture, Sutro Spinout Aims For Better Vaccines | Alex Lash | 07/23/15 | San Francisco |
| Biopharmaceutical Haiku, Round Two | Stewart Lyman | 07/06/15 | Seattle |
